# Prevalence of high-risk plasma p-tau217 levels and 5-year transition of risk status in 70-year-olds.

- **DOI:** [10.1002/alz.71545](https://doi.org/10.1002/alz.71545)
- **Rating:** Sound (3.4 out of 5)
- **Verdict:** A useful community cohort maps p-tau217 risk transitions over five years, but differential attrition limits the follow-up prevalence and prognostic interpretation.
- **Framework version:** v5.9
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-10-08
- **Evaluation page:** https://www.nabu.science/paper/10.1002%2Falz.71545

## Key claims

1. High-risk plasma p-tau217 prevalence was 3.6% at age 70 and 7.0% at age 75-77 years.
   - Support: Tentative
   - Type: Primary finding
   - Basis: the follow-up percentage is based on a retained cohort after substantial differential attrition
   - Location: Abstract; Results, Prevalence of high-risk plasma p-tau217
2. Individuals with low-risk plasma p-tau217 were unlikely to transition over 5-7 years.
   - Support: Supported
   - Type: Secondary
   - Basis: the repeated cohort shows 89% remained low-risk, although attrition limits population-level inference
   - Location: Abstract, Discussion
3. Prevalence of dementia at follow-up was 1.7% if remaining in the low-risk group and 21.4% if transitioning to the high-risk group.
   - Support: Supported
   - Type: Secondary
   - Basis: the reported contrast is direct but rests on a small transition group without precision estimates
   - Location: Abstract; Results, Cognitive outcomes at follow-up
4. Individuals who transitioned to a higher risk-category over time also had a higher prevalence of cognitive disability at follow-up, demonstrating increased risk for future cognitive decline among community-dwelling 70-year-olds.
   - Support: Tentative
   - Type: Secondary
   - Basis: concurrent follow-up measurements support association but do not establish subsequent future decline
   - Location: Discussion, Conclusion
5. The increase in plasma p-tau217 concentrations was higher among individuals who increased in CDR.
   - Support: Tentative
   - Type: Secondary
   - Basis: one supporting progression comparison contains an impossible median and interquartile range
   - Location: Results, Characteristics of participants stratified by plasma p-tau217 at baseline and follow-up

## Strengths

- **Longitudinal community biomarker measurements** The study measures plasma p-tau217 in 1,157 participants at baseline and in 771 participants at both waves, addressing a documented gap in repeated community-based estimates.
  - Dimension: contribution
  - Location: Methods, Design and Participants; Research in Context
- **Transparent follow-up accounting** Loss to follow-up is reported by baseline risk category, including the markedly higher loss from the high-risk group. This makes the principal selection limitation visible to readers.
  - Dimension: methodological rigour
  - Location: Results, Loss to follow-up
- **Cutoff uncertainty directly examined** The analysis tests whether transitioners cluster in the uncertain regions around the cutoffs and reports no clear overall pattern, directly addressing one possible source of category instability.
  - Dimension: methodological rigour
  - Location: Results, The influence of confidence intervals for rate of transition; Figure S1

## Limitations

- **Impossible reported median and IQR** For participants progressing from CDR 0.5, the reported median change of 0.25 pg/mL lies below the IQR lower bound of 0.28 pg/mL. The affected progression comparison cannot be accepted as printed.
  - Dimension: methodological rigour
  - Location: Results, Characteristics of participants stratified by plasma p-tau217 at baseline and follow-up
- **Differential attrition remains uncorrected** Loss reached 67% among baseline high-risk participants versus 32% among low-risk participants, yet no weighting or missing-data sensitivity analysis is reported. The 7.0% follow-up estimate therefore describes the retained sample rather than a securely estimated population prevalence.
  - Dimension: methodological rigour
  - Location: Results, Loss to follow-up; Discussion, Limitations
- **Prospective conclusion exceeds design** Transition status and cognitive status are assessed at the same follow-up visit, but the conclusion says this demonstrates future cognitive decline. The evidence supports a concurrent association, not that prospective inference.
  - Dimension: reporting
  - Location: Discussion, Conclusion

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Noted
  - The increase in plasma p-tau217 concentrations was higher among individuals who increased in CDR: "Similarly, increases in plasma p‐tau217 were higher in individuals who increased from CDR 0.5 at baseline to a higher CDR at follow‐up (0.02 [0.00–0.04] pg/mL and 0.25 [0.28–0.45] pg/mL respectively, median [IQR], p‐value = 0.001)." (Results, Characteristics of participants stratified by plasma p-tau217 at baseline and follow-up). The reported median of 0.25 pg/mL is below the first quartile of 0.28 pg/mL, violating the required ordering Q1 ≤ median ≤ Q3. → Effect on result unclear
- **Reporting and transparency:** Clean. No supplied concern establishes a reporting or research-conduct finding.
  - Conflict of interest: declared · Ethics approval: declared
- **Reference integrity:** Clean
  - 32 references in manuscript
  - 32 of 32 checkable references found in an index
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
